X

VIDEO: PhRMA CEO discusses industry response to opioid crisis on Mornings with Maria

Holly Campbell
Holly Campbell October 12, 2017

SJU photo_cropped-932000-edited.jpg.

Share This

PhRMA president and CEO Stephen J. Ubl joined Fox Business’ Maria Bartiromo on “Mornings with Maria” today to discuss bold steps the biopharmaceutical industry has taken in the last few months as part of its commitment to advance a multifaceted solution to address the opioid crisis. Most recently, PhRMA announced its support for policies limiting the supply of opioids to seven days for acute pain treatment.

PhRMA has also been working closely with the President’s Commission on Combating Drug Addiction and the Opioid Crisis, the National Institutes of Health (NIH) and the Food and Drug Administration to develop a public-private partnership that will accelerate the development of non-opioid, non-addictive pain medicines and medication-assisted treatments for long-term addiction recovery. The public-private partnership would allow increased information sharing and collaboration between government and industry to speed the drug development process.

Topics: FDA, Patients, Prescription Drug Safety